INTRODUCTION {#s1}
============

Filamentous fungi produce numerous secondary metabolites that are, per definition, not required for growth or development, as is the case for primary metabolites. Instead, secondary metabolites confer an advantage to producing fungi under specific environmental conditions, oftentimes mediating intra- and interspecies communication, pathogenicity, and defense against physical damage or competitors ([@B1], [@B2]). Mycotoxins are fungal secondary metabolites that are toxic to animals and accumulate in crops, but they often exhibit toxicity to other eukaryotes, including fungi ([@B3], [@B4]). This raises the question: how do fungi protect themselves from the mycotoxins they produce? In fungi, genes directly involved in the biosynthesis of a secondary metabolite are generally located next to one another in biosynthetic gene clusters ([@B5]). Such clusters often comprise one or more genes that confer self-protection against the toxic product of the cluster. Mechanisms of self-protection include (i) duplicated or resistant targets, generally enzymes of primary metabolism; (ii) detoxification by biotransformation to less harmful derivatives; and (iii) specific transporters that secrete toxins from the cytosol ([@B6]).

Among the most studied fungal mycotoxins are fumonisins of the B series (FBs), secondary metabolites produced by *Fusarium* and *Aspergillus* species ([@B7]). The predominant FB producer Fusarium verticillioides is the most prevalent fungus associated with contamination of corn and corn-derived products worldwide, and the consumption of FB-containing food and feed has been correlated with a number of human and animal diseases ([@B8], [@B9]). FB are polyketide-derived aminopentol compounds with two tricarballylic esters ([@B10], [@B11]), and particularly the analog FB~1~ ([Fig. 1](#fig1){ref-type="fig"}) is an efficient inhibitor of ceramide synthase, a key enzyme in sphingolipid biosynthesis ([@B12]). Appropriately, FB~1~ competes reversibly with both sphinganine and acyl coenzyme A (acyl-CoA) in the ceramide synthase active site ([@B13]). During plant infection, or after consumption of contaminated food and feed, inhibition of ceramide synthase results in the accumulation of free sphingoid bases, primarily sphinganine ([@B9], [@B14], [@B15]). Toxicity is attributed to apoptotic processes initiated in response to sphingoid base accumulation rather than reduced sphingolipid biosynthesis ([@B16]).

![Fumonisin (*FUM*) biosynthetic gene cluster, and proposed biosynthetic pathway toward fumonisin B~1~ (FB~1~). Genes encoding FB~1~ biosynthetic enzymes are depicted in black. *FUM21* (white) encodes the cluster-specific transcription factor, while the coregulated cluster genes *FUM15* to *FUM19* (gray) do not participate in FB~1~ biosynthesis.](mBio.00455-20-f0001){#fig1}

Complex sphingolipids consist of a ceramide backbone, i.e., sphingosine attached to a fatty acid (C~14~ to C~26~) in an amide linkage, with a polar headgroup ([@B17]). They are essential components of eukaryotic cellular membranes, which are involved in maintaining proper membrane structure and anchoring membrane-associated proteins. Sphingolipid biosynthesis is compartmentalized: the first steps take place in the endoplasmic reticulum (ER), while complex sphingolipids are produced in the Golgi apparatus ([@B18]). As indicated, precursors/degradation products of sphingolipids act as second messengers, therefore, sphingolipid metabolism is tightly controlled ([@B16]). Thus, when applied in a targeted manner, sphingolipid biosynthesis inhibitors can serve as treatment against severe human diseases, e.g., cancer, Alzheimer's, schizophrenia, multiple sclerosis, and diabetes, that are (among other defects) correlated with a deregulated sphingolipid metabolism ([@B17], [@B19], [@B20]).

In F. verticillioides, the FB biosynthetic gene cluster (*FUM*) includes 16 genes: *FUM1* to *FUM3*, *FUM6* to *FUM8*, *FUM10*, *FUM11*, *FUM13* to *FUM19*, and *FUM21* ([@B11], [@B21]). FB biosynthesis is initiated when the polyketide synthase Fum1 catalyzes synthesis of an octadecanoic acid precursor, which then undergoes condensation with [l]{.smallcaps}-alanine, a reaction catalyzed by the aminotransferase Fum8 ([Fig. 1](#fig1){ref-type="fig"}). The cluster encodes a tricarboxylate transporter, Fum11, likely functioning as a mitochondrial carrier protein and providing the substrate for Fum7 and Fum10 to produce CoA-activated tricarballylic acid. Two of these molecules are attached to the polyketide backbone by Fum14, while the final biosynthetic step is performed by the dioxygenase Fum3 ([@B22]). In addition, the cluster encodes a transcriptional regulator, Fum21, belonging to the GAL4-like Zn(II)~2~Cys~6~ transcription factor family ([@B21]). Despite all of the functional analyses of *FUM* cluster genes, the functions of *FUM15* to *FUM19* remain unclear ([@B11]). Also, the mechanism that protects F. verticillioides ceramide synthases from the inhibitory effect of FB has not yet been elucidated. While FB~1~ has antifungal activity, in particular against FB nonproducers, F. verticillioides was more resistant to externally added FB~1~ ([@B23]). Knowledge of this process has potential to provide new insights into methods to block FB production in crops and thereby improve food safety.

The similarity of Fum17 and Fum18 to ceramide synthases and of Fum19 to ATP-binding cassette (ABC) transporters suggests a role for these proteins in FB self-protection ([@B11]). In the present work, we demonstrate that Fum19 is involved in *FUM* cluster regulation, acting as a repressor of biosynthesis. Point mutations of the identified ATP-binding domains indicated that ATP hydrolysis and possibly transport are required for Fum19 activity. Moreover, confocal microscopy showed that the aminotransferase Fum8 colocalizes with Fum17, Fum18, and the fungal ceramide synthase Cer1 in ER-derived vesicles. The results presented here show that Fum18 constitutes a *FUM* cluster-encoded ceramide synthase as an additional toxin-targeted enzyme, which contributes to ceramide biosynthesis and thereby decreases self-poisoning.

RESULTS {#s2}
=======

The ABC transporter Fum19 acts as a repressor of the *FUM* gene cluster. {#s2.1}
------------------------------------------------------------------------

In order to analyze the influence of *FUM17*, *FUM18*, and *FUM19* on FB biosynthesis and fungal self-protection, we generated single deletion mutants in F. verticillioides strain M-3125. We also generated both double *FUM17/18* and triple *FUM17-19* deletion mutants to test for functional redundancy. Because FB~1~ is the FB analog produced in greatest abundance by F. verticillioides, i.e., FB~1~ constitutes approximately 80% of total FB ([@B11]), we used it as a marker for FB production. FB~1~ production was quantified in shaking cultures by high performance liquid chromatography coupled to high-resolution mass spectrometry (HPLC-HRMS). The identity of the chromatographic peak corresponding to FB~1~ was verified by comparison with an FB~1~ reference (see [Fig. S1A](#figS1){ref-type="supplementary-material"} and [B](#figS1){ref-type="supplementary-material"} in the supplemental material).
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Chemical analyses of FB~1~. (A) HPLC-HRMS comparison of FB~1~ produced by the F. verticillioides WT with the chemical standard. (B) Extracted ion chromatograms for *m*/*z *=* *722.3957 ± 5 ppm and measured accurate masses. (C) Intracellular accumulation of FB~1~ in Δ*fum17-19*, Δ*fum19*, and OE::*FUM19* mutants. Extracts from washed mycelium were analyzed via HPLC-HRMS. (D) The fungal biomasses of *FUM17*, *FUM18*, and *FUM19* mutants were determined after freeze-drying the harvested mycelium. Indicated strains were grown in ICI/6 mM Gln shaking culture for 7 days. FB~1~ production and biomass of the WT were arbitrarily set to 100%, respectively. The data are means ± the standard deviations (*n *=* *3). For statistical analysis, the mutants were compared to the WT using the Student *t* test (\*, *P* \< 0.05). Download FIG S1, PDF file, 0.1 MB.
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Single and double deletion of *FUM17* and *FUM18* did not affect FB~1~ production ([Fig. 2A](#fig2){ref-type="fig"}), confirming previously reported results ([@B11]). However, deletion of *FUM19*, in both wild-type (WT) and Δ*fum17/18* backgrounds, resulted in significant overproduction of FB~1~ in the supernatant as well as in the extracted mycelium ([Fig. 2A](#fig2){ref-type="fig"}; [Fig. S1C](#figS1){ref-type="supplementary-material"}). In contrast, *FUM19* overexpression resulted in a significant reduction in FB~1~ production ([Fig. 2A](#fig2){ref-type="fig"}; [Fig. S1C](#figS1){ref-type="supplementary-material"}). Despite elevated FB~1~ levels in Δ*fum19* mutants, fungal biomass was not decreased compared to the WT ([Fig. S1D](#figS1){ref-type="supplementary-material"}). The overall production of FB~1~ correlated very well with *FUM* cluster gene expression. Indeed, the Δ*fum19* mutant exhibited elevated expression of *FUM17* and *FUM18*, as well as *FUM8*, which served as a marker for *FUM* genes encoding FB biosynthetic enzymes ([Fig. 2B](#fig2){ref-type="fig"}). Together, these results indicated that *FUM19* negatively impacts expression of other *FUM* cluster genes, which in turn indicated a repressive role of Fum19 in FB biosynthesis.

![FB~1~ production and *FUM* gene expression in *FUM17*, *FUM18*, and *FUM19* mutants. (A) FB~1~ was relatively quantified in shaking cultures. Indicated strains were grown in ICI/6 mM Gln for 7 days, and cell-free culture fluids were analyzed via HPLC-HRMS. The production level of the WT was arbitrarily set to 100%. The data are mean values ± standard deviation (*n *=* *3). (B) After 2 days of cultivation, the relative expression (RE) was determined by qRT-PCR. The WT gene expression was arbitrarily set to 1. The data are means ± the standard deviations (*n *=* *3). For statistical analysis, the mutants were compared with the WT using the Student *t* test (\*, *P* \< 0.05; \*\*, *P* \< 0.01; \*\*\*, *P* \< 0.001).](mBio.00455-20-f0002){#fig2}

We hypothesized that this regulatory role of Fum19 may be linked to its ability to bind and transport FB~1~ at the expense of ATP. In order to test whether ATP hydrolysis is required for this regulatory role, we performed site-directed mutagenesis of the two putative Fum19 ATP-binding domains ([Fig. 3A](#fig3){ref-type="fig"}). The domains were identified by comparison of the deduced amino acid sequence of Fum19 to the ATP-binding domain of the Salmonella enterica serovar Typhimurium histidine permease, HisP, which has been structurally resolved and thoroughly analyzed with respect to structure-function relationships ([@B24], [@B25]). The comparison led to identification of two sets of amino acids (K631/K1260 and D743/D1397) predicted to be critical for binding of ATP to Fum19 ([@B25]). In an attempt to disable ATP-binding and thereby block the presumed transport function of Fum19, we introduced two sets of point mutations into cloned *FUM19* that were designed to replace the K631/K1260 (*FUM19^Kmut^*) or D743/D1397 (*FUM19^Dmut^*) residues in the Fum19 protein ([Fig. 3A](#fig3){ref-type="fig"}; [Fig. S2A](#figS2){ref-type="supplementary-material"}). *In locus* exchange of Δ*fum19* with the WT gene, *FUM19^C^*, restored FB~1~ production to close to WT levels ([Fig. 3B](#fig3){ref-type="fig"}). However, exchange with either *FUM19^Kmut^* or *FUM19^Dmut^* did not complement the Δ*fum19* phenotype ([Fig. 3B](#fig3){ref-type="fig"}). We confirmed that *FUM19* expression was comparable for all complemented strains ([Fig. S2B](#figS2){ref-type="supplementary-material"}). These experiments suggested that ATP hydrolysis, and possibly transport, are tightly coupled to the regulatory role of Fum19. However, because extracellular FB~1~ accumulated upon deletion or point mutation of *FUM19*, we can hypothesize that either F. verticillioides harbors additional FB~1~ exporters or that the molecule is able to passively cross the plasma membrane.

![Deletion and point-mutation of *FUM19* upregulates the *FUM* cluster. (A) Schematic representation of the two sets of point mutations inserted into the ATP-binding domains (ATP BD) of *FUM19*. (B) The indicated strains were grown in ICI/6 mM Gln shaking culture for 7 days and analyzed by HPLC-HRMS. Culture fluids were measured directly, while metabolite extraction from washed mycelium was performed for intracellular FB~1~ levels. The production level of the WT was arbitrarily set to 100%. The data are means ± the standard deviations (*n *=* *3). (C) After 2 days of cultivation, relative expression (RE) was determined by qRT-PCR. The WT gene expression was arbitrarily set to 1. The data are means ± the standard deviations (*n *=* *3). For statistical analysis, strains were compared as indicated using the Student *t* test (\*, *P* \< 0.05; \*\*, *P* \< 0.01; \*\*\*, *P* \< 0.001).](mBio.00455-20-f0003){#fig3}
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*FUM19* point mutation and FB~1~ feeding of *FUM19* and *FUM21* mutants. (A) The two ATP-binding domains of Fum19 were identified by comparison to the respective domain of HisP (UniProtKB [P02915](https://www.ncbi.nlm.nih.gov/protein/P02915)). Identical amino acids are highlighted in gray, and residues chosen for point mutation are marked. (B) Expression analysis of *FUM19* point-mutated strains, grown in an ICI/6 mM Gln shaking culture for 2 days. (C) For FB~1~ feeding, the indicated strains were grown in an ICI/6 mM Gln shaking culture for 1 or 2 days prior to the addition of water (untreated) or 10 μg/ml FB~1~ for 2 h. The relative expression (RE) was determined by qRT-PCR, and WT gene expression (2 days) was arbitrarily set to 1. The data are means ± the standard deviations (*n *=* *3). For statistical analysis, treated and untreated samples were compared using the Student *t* test (\*\*, *P* \< 0.01; \*\*\*, *P* \< 0.001). Download FIG S2, PDF file, 0.1 MB.
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Fum17 and Fum18 are partially regulated by Fum21. {#s2.2}
-------------------------------------------------

Expression analysis via quantitative real-time PCR (qRT-PCR) of *FUM19* deletion and overexpression strains revealed that the cluster-specific transcription factor gene *FUM21* was not coordinately up- or downregulated, respectively ([Fig. 2B](#fig2){ref-type="fig"}). This suggested that the negative feedback mediated by Fum19 does not occur via *FUM21* repression on a transcriptional level.

To investigate this further, we deleted *FUM21* in the WT and Δ*fum19* mutant strains of F. verticillioides. In both genetic backgrounds, the deletion completely abolished FB~1~ production, confirming that Fum21 is essential for biosynthesis ([Fig. 3B](#fig3){ref-type="fig"}). However, in contrast to *FUM8*, *FUM17* and *FUM18* expression was only partially under the control of Fum21, as their expression was induced in ∆*fum19*/∆*fum21* double mutants ([Fig. 3C](#fig3){ref-type="fig"}). It is noteworthy that this expression occurred in the complete absence of FB~1~ production, highlighting that cluster activation in the Δ*fum19* background is not a consequence of intracellular accumulation of FB~1~. Nonetheless, addition of exogenous FB~1~ induced expression of *FUM8*, *FUM17*, *FUM18*, and *FUM19*, but not *FUM21*, in the WT background ([Fig. S2C](#figS2){ref-type="supplementary-material"}). Upregulation of *FUM8*, *FUM17*, and *FUM18* by the addition of FB~1~ was independent of the presence of a functional *FUM19* but largely dependent on the presence of a functional *FUM21* ([Fig. S2C](#figS2){ref-type="supplementary-material"}).

Taken together, these experiments revealed complex and intertwined regulation mechanisms of the *FUM* gene cluster: *FUM19* repressed *FUM* cluster genes in the WT background, whereas deletion of *FUM19* strongly upregulated FB~1~ production. *FUM21* was essential for FB~1~ production, and both *FUM8* and *FUM19* were tightly regulated by the transcription factor. In contrast, expression of *FUM17* and *FUM18* could still be induced in the Δ*fum21* background.

Phylogenetic relationships of Fum17 and Fum18 to other fungal ceramide synthases. {#s2.3}
---------------------------------------------------------------------------------

An analysis of the deduced amino acid sequences of Fum17 and Fum18 revealed that both proteins have a TRAM/LAG1/CLN8 (TLC) protein domain (IPR006634), a domain that is present in all eukaryotic ceramide synthases described to date ([@B26]). To gain insight in the relationships of Fum17 and Fum18 to other fungal ceramide synthases, we inferred a phylogenetic tree using alignments of predicted amino acid sequences retrieved by BLAST analysis of selected genome sequences at the National Center for Biotechnology Information (NCBI)-GenBank and Joint Genome Institute. Because *Fusarium* is a member of the phylum Ascomycotina (class Sordariomycetes), most sequences were retrieved from other ascomycetous fungi, including species in classes Dothideomycetes, Eurotiomycetes, Leotiomycetes, Pezizomycetes, Saccharomycetes, and Sordariomycetes. We also retrieved sequences from five species in phylum Basidiomycotina. In the resulting phylogenetic tree, fungal ceramide synthases were resolved into two major clades, designated CS-I and CS-II ([Fig. 4](#fig4){ref-type="fig"}). Most species of the Ascomycotina and Basidiomycotina included in this analysis had at least one ceramide synthase in each of the major clades. However, the *LAG1* and *LAC1* genes from yeast species were an exception to this; *LAG1* and *LAC1* were both resolved within clade CS-I and were relatively closely related to one another. *Fusarium* species with the *FUM* cluster had three ceramide synthase genes (*CER1*, *CER2*, and *CER3*) located outside the cluster, in addition to the cluster genes *FUM17* and *FUM18*. *FUM17* homologs from Fusarium fujikuroi and Fusarium proliferatum were excluded from the analysis because the gene was pseudogenized in these species. In the tree, *FUM17* and *CER1* (*FVEG_06971*) were resolved within clade CS-I, while *FUM18*, *CER2* (*FVEG_12887*), and *CER3* (*FVEG_15375*) were resolved in clade CS-II ([Fig. 4](#fig4){ref-type="fig"}). Fusarium solani was unique in that it had a fourth non-*FUM*-cluster ceramide synthase gene that was resolved within clade CS-I and that was relatively distantly related to other *Fusarium* genes, but instead was most closely related to homologs in the sordariomycete species *Gaeumannomyces tritici* and *Pyricularia oryzae* ([Fig. 4](#fig4){ref-type="fig"}). Conclusively, phylogenetic analysis revealed that Fum17 and Fum18 are closely related to fungal ceramide synthases.

![Phylogenetic tree showing two major clades (CS-I and CS-II) of fungal ceramide synthases and the positions of Fum17 and Fum18 within the clades. The tree was inferred by maximum-likelihood analysis of alignments of predicted amino acid sequences of selected ceramide synthases from the ascomycete classes Dothideomycetes, Eurotiomycetes, Leotiomycetes, Pezizomycetes, Saccharomycetes and Sordariomycetes. Sequences of five basidiomycete species were also included in the analysis, and the tree was rooted with rat and human sequences. Accession numbers for protein sequences are indicated after species names. Joint Genome Institute accession numbers are preceded by JGI; all other accessions are from NCBI/GenBank. In the Fum17 and Fum18 clades, the five-digit numbers after some of the *Fusarium* species names are NRRL strain designation. The genome sequences of these are present in GenBank, but they are not annotated. Numbers near branches are bootstrap values based on 1,000 pseudoreplicates. Values of \<70 are not considered to be significant and therefore are not shown.](mBio.00455-20-f0004){#fig4}

Fum17, Fum18, Fum8, and Cer1 colocalize in ER-derived vesicles. {#s2.4}
---------------------------------------------------------------

Next, we performed localization studies by confocal microscopy of Fum17 and Fum18, C-terminally fused to green and red fluorescent proteins (GFP/DsRed), respectively. We made sure that the fluorescent proteins did not give signals when excited with inappropriate wavelengths ([Fig. S3](#figS3){ref-type="supplementary-material"}). Fum17-GFP and Fum18-DsRed were shown to colocalize with each other in the perinuclear ER, and their localization around the nuclei was verified by nuclear visualization, i.e., staining with the DNA-binding dye Hoechst 33342. In addition, they colocalized in the membrane of small/medium-sized vesicles (ca. 1 to 2 μm) which were independent of the nuclei ([Fig. 5A](#fig5){ref-type="fig"}). Full colocalization of both proteins with one of the three ceramide synthase homologs, Cer1 fused to blue fluorescent protein (BFP), confirmed their presence in the perinuclear ER and in ER-derived vesicles ([Fig. 5B](#fig5){ref-type="fig"}). The presence of DsRed-Fum8 (N-terminal fusion) in the vesicles, but not in the perinuclear ER, revealed that early FB biosynthesis takes place in these compartments ([Fig. 5C](#fig5){ref-type="fig"}). Intriguingly, the final FB biosynthetic step performed by the dioxygenase Fum3 takes place in the cytoplasm, as shown by C-terminal GFP fusion ([Fig. 5D](#fig5){ref-type="fig"}). In summary, these results strongly indicated that biosynthesis of both sphingolipids and inhibitors thereof partially overlap, while the final biosynthetic step is separate from Fum17, Fum18, and Cer1.

![Fum3, Fum8, Fum17, Fum18, and Cer1 localization in F. verticillioides. Confocal microscopy for localization of Fum17-GFP and Fum18-DsRed (A), Cer1-BFP (B), DsRed-Fum8 (C), and Fum3-GFP (D). Conidia were inoculated in ICI/6 mM Gln and grown as a standing culture overnight. The indicated double mutants were analyzed for GFP, DsRed, and/or BFP fluorescence. The cells were untreated, except when indicated (nuclear staining with Hoechst 33342 in panel A). Shown are individual channels in black/white, bright-field (BF) images and an overlay with the BF in color.](mBio.00455-20-f0005){#fig5}
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Confocal microscopy for localization of Fum17-GFP and Fum18-DsRed. Conidia were inoculated in ICI/6 mM Gln and grown as a standing culture overnight. The indicated strains were analyzed for GFP, DsRed, and BFP fluorescence. Shown are individual channels in black/white, bright-field (BF) images and an overlay with BF in color. Download FIG S3, PDF file, 0.8 MB.
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Fum18 is a functional ceramide synthase. {#s2.5}
----------------------------------------

In order to investigate whether Fum17 and Fum18 function as ceramide synthases, we established a yeast complementation assay. As indicated above, the Saccharomyces cerevisiae genome encodes two paralogs of clade CS-I with redundant function, Lag1 and Lac1. *LAG1*/*LAC1* double deletion mutants are nonviable or very slow growing ([@B27], [@B28]). Therefore, we constructed a conditional null mutant, in which *LAG1* is under the control of the inducible *TET^ON^* promoter ([@B29]) in the Δ*lac1* background. The resulting strain could grow only in the presence of doxycycline ([Fig. 6A](#fig6){ref-type="fig"}). As shown, the two S. cerevisiae ceramide synthase genes, either *LAG1* or *LAC1*, could rescue the lethal phenotype when expressed from a plasmid under the control of the constitutive *TEF1* promoter (*Ptef1*) ([Fig. 6A](#fig6){ref-type="fig"}).

![Yeast complementation and resazurin cell viability assays for analyzing ceramide synthase functionality and inhibition, respectively. (A) The conditionally lethal strain S. cerevisiae Δ*lac1*/TET::*LAG1* was complemented with yeast (green), F. verticillioides (blue) and human (violet) ceramide synthase homologs. Complementation of the null mutant was evaluated in the absence of inducer (0 μg/ml doxycycline) after 2 days on SD--Ura (*n *=* *2). (B) Plasmid *Ptef1*::*FvCER3* was introduced into S. cerevisiae WT, Δ*lac1*, and Δ*lag1* backgrounds. (C to E) Resazurin assay with S. cerevisiae Δ*lac1*/TET::*LAG1* strains (500 μg/ml FB~1~) (C), S. cerevisiae WT strains (500 μg/ml FB~1~) (D), and F. verticillioides *FUM17/18* mutants (250 μg/ml FB~1~) (E). Growth curves used for the calculations are shown in [Fig. S4](#figS4){ref-type="supplementary-material"}. In each case, inhibition of the control strain was arbitrarily set to 100%. The data are means ± the standard deviations (*n *=* *3). For statistical analysis, strains were compared as indicated or with the control using the Student *t* test (\*, *P* \< 0.05; \*\*, *P* \< 0.01; \*\*\*, *P* \< 0.001).](mBio.00455-20-f0006){#fig6}
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Resazurin cell viability assays. (A) Plasmid-harboring S. cerevisiae Δ*lac1*/TET::*LAG1* strains were grown in SD--Ura without doxycycline for 24 h. (B) Plasmid-harboring S. cerevisiae WT strains were grown in SD--Ura for 24 h. (C) F. verticillioides WT and *FUM17/18* mutants were grown in ICI/6 mM Gln for 21 h. Fluorescence was detected every 30 min. Each strain was incubated under the addition of water (untreated) or FB~1~ as indicated. To account for medium- and compound-related variations, measurements of each sample were normalized against its lowest starting value. The data are means ± the standard deviations (*n *=* *3). Download FIG S4, PDF file, 0.2 MB.
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We expressed the five F. verticillioides TLC domain proteins (*CER1*, *CER2*, *CER3*, *FUM17*, and *FUM18*) in the Δ*lac1*/TET::*LAG1* background. As shown, expression of *CER1*, *CER2*, or *FUM18* fully complemented the S. cerevisiae null mutant in the absence of doxycycline ([Fig. 6A](#fig6){ref-type="fig"}). In contrast, *FUM17* and *CER3* did not complement the mutant, and the expression of *CER3* was even toxic for S. cerevisiae ([Fig. 6A](#fig6){ref-type="fig"} and [B](#fig6){ref-type="fig"}). Intriguingly, expression of a bicistronic *FUM17*::*CER3* construct partially complemented Δ*lac1*/TET::*LAG1* in the absence of doxycycline ([Fig. 6A](#fig6){ref-type="fig"}). This suggested that Cer3 is able to form nonfunctional heterodimers with both Lag1 and Lac1, while it can functionally dimerize with Fum17. These data indicated that the *FUM* gene cluster encodes a functional ceramide synthase, Fum18, while Fum17 can potentially contribute to ceramide biosynthesis by interaction with Cer3.

Fum18 contributes to resistance against FB~1~. {#s2.6}
----------------------------------------------

In order to test whether Fum18, Cer1, and Cer2 are insensitive to FB~1~, we established a resazurin cell viability assay for S. cerevisiae and *Fusarium* strains generated during this study. The blue nonfluorescent dye resazurin is reduced to its pink highly fluorescent derivative resorufin, and this turnover is proportional to respiration processes in living cells, including fungi ([@B30], [@B31]). In a previous study, real-time monitoring of bacterial growth revealed that fluorescence was proportional to cell density, allowing the assay to be used to compare treatments that differ in effect on growth ([@B32]). We adapted this protocol for S. cerevisiae and F. verticillioides strains exposed to FB~1~, where the difference in fluorescence maxima between nontreated and FB~1~-treated cells represented the growth-inhibitory effect for a given strain and was independent of the growth rate ([Fig. S4](#figS4){ref-type="supplementary-material"}). Both fungi exhibit an intrinsic tolerance to FB~1~; therefore, relatively high concentrations of FB~1~ (250 to 500 μg/ml) were used in experiments to observe differences in inhibition ([Fig. 6C](#fig6){ref-type="fig"} to [E](#fig6){ref-type="fig"}).

In order to include human ceramide synthases in the susceptibility tests, *CERS2*, *CERS4*, *CERS5*, and *CERS6* were amplified from cDNA of the colon cancer cell line HT29-MTX ([@B33]). Sequence analysis of the cDNA identified a previously unreported insertion in *CERS6* that resulted in a frameshift and early termination, producing a predicted protein of 349 rather than 384 amino acids (K334 → KVLVILTCFYSTGVQG). Although these human ceramide synthases harbor a homeobox (HOX) domain (IPR001356) and thereby differ structurally from the fungal homologs, *CERS2*/*CERS4*/*CERS6* fully, and *CERS5* partially complemented Δ*lac1*/TET::*LAG1* ([Fig. 6A](#fig6){ref-type="fig"}).

We first analyzed Δ*lac1*/TET::*LAG1* strains complemented with either one of the fungal or human ceramide synthase genes and grown in the absence of inducer ([Fig. S4A](#figS4){ref-type="supplementary-material"}). Compared to yeast Lag1 and Lac1, human CERS4 and CERS6 were more strongly inhibited by FB~1~ (500 μg/ml), although the difference for CERS6 was not significant ([Fig. 6C](#fig6){ref-type="fig"}). Among the F. verticillioides homologs, Cer2 was more strongly inhibited than Cer1 and Fum18. Coexpression of *FUM17* and *FUM18* did not further increase tolerance to FB~1~, suggesting that they do not cooperate in FB~1~ resistance ([Fig. 6C](#fig6){ref-type="fig"}). Based on this result, we can assume that Fum18 is not an intrinsically more resistant ceramide synthase variant but that it contributes to fungal self-protection by providing additional cluster-encoded ceramide synthase activity. To confirm this assumption, we expressed *CER1*, *CER2*, and *FUM18* in WT S. cerevisiae to generate strains with a third ceramide synthase gene in addition to *LAG1* and *LAC1*. The results of growth assays indicated that heterologous expression of any of these F. verticillioides genes significantly increased tolerance of S. cerevisiae to FB~1~ ([Fig. 6D](#fig6){ref-type="fig"}; [Fig. S4B](#figS4){ref-type="supplementary-material"}). The finding for *CER2* was surprising given that initial assessment indicated that Cer2 was less tolerant to FB~1~ than Cer1 and Fum18 ([Fig. 6C](#fig6){ref-type="fig"}).

Finally, we examined germinating conidia of the Δ*fum17*, Δ*fum18*, and Δ*fum17/18* mutant and WT strains of F. verticillioides in the presence or absence of FB~1~ (250 μg/ml). Young hyphae of the single and double deletion mutants of *FUM18* were more susceptible to FB~1~, which could be complemented by reintroduction of the full-length gene in the Δ*fum18* background ([Fig. 6E](#fig6){ref-type="fig"}; [Fig. S4C](#figS4){ref-type="supplementary-material"}). In summary, Fum18 is a functional ceramide synthase which confers additional cluster-encoded enzymatic activity, and thereby fungal self-protection against the produced ceramide synthase inhibitor FB~1~.

DISCUSSION {#s3}
==========

The biosynthesis of fungal secondary metabolites is highly regulated not only in terms of cluster gene expression but also concerning the spatial organization of the encoded enzymes. Like all eukaryotes, fungal cells contain small organelles and vesicles able to embed enzymes and potentially compartmentalize biosynthetic pathways. This mechanism has several advantages: (i) it concentrates enzymes in a smaller space, improving multienzymatic catalysis; (ii) it reduces cross-reactions with other biosynthetic pathways; and (iii) in the case of production of mycotoxins, it may protect cells from self-poisoning ([@B34]).

In the present study, we identified highly sophisticated compartmentalization, regulation and self-protection mechanisms, which ensure tightly controlled levels of the ceramide synthase inhibitor FB~1~ in F. verticillioides. Compartmentalization of FB biosynthesis makes sense for two reasons. First, compartmentalization allows for spatially restricted and thereby controlled biosynthesis. The early FB pathway enzyme Fum8 was localized to ER-derived vesicles ([Fig. 7](#fig7){ref-type="fig"}), and indeed the duplicated target enzyme, the ceramide synthase Fum18, was found to colocalize with Cer1 in these vesicles. It is noteworthy that ceramide biosynthesis likely occurs on the perinuclear ER ([@B35]), which was nearly completely devoid of Fum8. Second, the last biosynthetic step, performed by Fum3, was localized to the cytoplasm, revealing that the most potent compound FB~1~ is separate from the fungal ceramide synthases ([@B36]). Appropriately, this compartmentalization strategy likely helps to prevent self-poisoning.

![Compartmentalization and self-protection strategies of the FB~1~ producer F. verticillioides. Fum8 is localized to ER-derived vesicles, in which also Fum17, Fum18, and Cer1 are found, while Fum3 is cytoplasmic. Fum18 is a functional ceramide synthase required for self-protection by providing additional enzymatic activity and thereby supporting Cer1 and Cer2. Fum17 could contribute to self-protection by forming a functional heterodimer with Cer3. The ABC transporter Fum19 is formally a repressor of the *FUM* gene cluster. This was supported by the fact that FB~1~ feeding triggered cluster gene expression, an effect which was mainly dependent on the cluster-specific transcription factor Fum21.](mBio.00455-20-f0007){#fig7}

Although Fum19 was not shown to be essential for FB~1~ export, the results reported here indicate that this ABC transporter has an important role in the regulation of expression of *FUM* cluster genes and thereby self-protection. This was supported by several lines of evidence. Deletion (in two different backgrounds) and overexpression of *FUM19* induced and reduced, respectively, the expression of other *FUM* genes, which is consistent with a role as repressor for Fum19 ([Fig. 7](#fig7){ref-type="fig"}). An earlier study on F. verticillioides Δ*fum19* reported a slight increase in FB~1~ and a significant decrease in its direct precursor FB~3~, indicating a shift toward the final product and thereby an upregulation of the biosynthetic pathway ([@B11]). We suggest that FB~1~ production in the WT background was not at its maximum under our cultivation conditions (fully synthetic 1-week culture), so that a more drastic increase could be observed for Δ*fum19*. Noteworthy, *FUM19* overexpression and a detailed analysis of intra- and extracellular FB~1~ levels had not been performed. On a transcriptional level, *FUM19* deletion in the Δ*fum21* background resulted in derepression of the resistance gene *FUM18* (and *FUM17*), indicating a regulatory circuit that directly targets *FUM* gene expression in the complete absence of either Fum21 or the final product FB~1~. Taken together, this indicates that Fum19 is involved in a negative-feedback loop to moderate FB~1~ levels, while Fum19 dysfunction, here mimicked by gene deletion and point mutations, gives a cue to upregulate expression of *FUM* cluster genes.

Point mutations of *FUM19* confirmed that ATP hydrolysis and thereby possibly transport are tightly linked to its function, although final proof that Fum19 is a true exporter is still lacking. At this point, it cannot be excluded that ATP sensing is (one of) the vital role(s) of Fum19. Nevertheless, these data are consistent with earlier reports, in which deletion of the associated ABC transporter gene resulted in an upregulated secondary metabolite biosynthesis, i.e., of gibepyrone and beauvericin in *F. fujikuroi* and of sirodesmin in *Leptosphaeria maculans* ([@B37][@B38][@B39]). Noteworthy, the beauvericin ABC transporter Bea3 was successfully localized to the plasma membrane, although it was not essential for secretion ([@B38]). This implies either that these mycotoxins may passively cross the plasma membrane or that additional cluster-independent exporters are responsible for their secretion. As an example, redundancy of exporters has been observed for cercosporin in *Cercospora nicotianae*: although the gene cluster encodes a transporter of the major facilitator superfamily (MFS), two exporters outside of the cluster were required for self-protection ([@B40], [@B41]). Interestingly, cluster upregulation upon deletion seems to be specific to ABC transporter genes, while the loss of MFS transporters has been mainly correlated with a downregulation of the cluster ([@B41], [@B42]).

Because the results from our analysis of *FUM19* function provided new insights into FB biosynthesis, we decided to reassess the functions of *FUM17* and *FUM18*. In the present study, we demonstrated that Fum18 can function as a ceramide synthase on its own and that it contributes to FB self-protection by providing supplementary ceramide synthase activity ([Fig. 7](#fig7){ref-type="fig"}). FB~1~ inhibited growth of *FUM18* deletion mutants during spore germination, but not when produced at a later stage in liquid cultures, since fungal biomass of *FUM18* mutants was not reduced compared to the WT. Indeed, it has been suggested that inhibition of sphingolipid metabolism is likely to be more disturbing for actively growing cells ([@B16], [@B36]), i.e., during spore germination in this case. In addition, Fum17 could contribute to FB self-protection by forming a heterodimer with Cer3. The later point is supported by the fact that homo- and heterodimers of Lag1/Lac1 have been reported for yeast ceramide synthase complexes ([@B43]).

The expression of additional ceramide synthase genes to decrease the toxic effect of sphingolipid biosynthesis inhibitors seems to be conserved. In this regard, FB~1~ and AAL-toxin display a highly similar chemical structure, and their biosynthesis is conferred by homologous gene clusters ([@B44], [@B45]). The *F. fujikuroi FUM* cluster and the Alternaria alternata AAL-toxin cluster harbor a *FUM18* homolog but lack a functional *FUM17* ([@B45], [@B46]). Alt7 of the AAL-toxin cluster was suggested to be a ceramide synthase homolog, although direct functional tests have not been reported ([@B45]). However, prior to that, it was shown that resistance in tomato to AAL-toxin-producing isolates of A. alternata was mediated by the plant ceramide synthase Asc-1. Tomato Asc-1 prevented programmed cell death which was otherwise induced upon disruption of sphingolipid biosynthesis by AAL-toxin ([@B47], [@B48]). Therefore, the presence of an additional target enzyme is a successful resistance strategy for both the plant and the fungal side.

The present study revealed that filamentous fungi have at least two ceramide synthase genes. Furthermore, phylogenetic analysis showed that they group into two distinct clades (CS-I and CS-II) and that within a given species, one is a member of CS-I and the other is a member of CS-II. *Fusarium* spp. and FB-producing *Fusarium* spp. can have three and (up to) five homologs, respectively. The phylogenetic relationships of *FUM17* and *FUM18* and their presence in the *FUM* cluster mirror the relationships and presence of two ceramide synthase genes in fungal genomes. The nesting of *FUM17* and *FUM18* within clades of sordariomycete genes suggests that they did not evolve from *Fusarium* genes, but instead evolved from genes in a sordariomycete ancestor. On a biochemical level, evidence suggests that fungal clade CS-I ceramide synthases provide precursors for glycosylinositol phosphorylceramide-type complex sphingolipids, while clade CS-II enzymes feed the glucosylceramide pool ([@B49], [@B50]). Deletion of Fusarium graminearum *BAR1*, the *FvCER3* ortholog, resulted in complete loss of glucosylceramide biosynthesis ([@B51]). Although Cer3 was not functional on its own in the yeast complementation assay, this does not exclude its functionality in F. verticillioides *in vivo*. It remains to be elucidated whether Cer2 and Fum18 homologs also contribute to the glucosylceramide pool in FB-producing *Fusarium* spp.

The yeast ceramide synthase assay developed in this study could be used to test novel (chemical) derivatives of sphingolipid biosynthesis inhibitors for improved or more specific ceramide synthase inactivation. The six human enzymes exhibit specificity with respect to carbon-chain length of fatty acyl-CoAs that they can use as the substrates ([@B18]). As a result, modification of FB~1~ to mimic CoA precursors of a specific chain length has potential as a strategy to inhibit one ceramide synthase without affecting others. Targeting individual human enzymes would have powerful therapeutic applications, such as specifically inactivating CERS6 upregulated during development of multiple sclerosis ([@B17]). In addition, the disruption of fungal sphingolipid metabolism has been suggested as an efficient antifungal strategy ([@B50]).

In summary, we presented a comprehensive analysis of compartmentalization strategies and cluster-encoded self-protection mechanisms involved in FB biosynthesis in F. verticillioides. The final step in FB biosynthesis, performed by the dioxygenase Fum3, was localized to the cytoplasm and does thereby not colocalize with fungal ceramide biosynthesis in the ER. In ER-derived membrane structures, Fum18 was shown to protect the fungal ceramide synthases Cer1 and Cer2 by providing *FUM* cluster-encoded ceramide synthase activity. In addition, the ABC transporter Fum19 indirectly contributes to self-protection by modulating FB levels through its effects on expression of *FUM* cluster genes. These findings provide insight into FB self-protection in fungi and point to novel methods for ceramide synthase-related drug discovery.

MATERIALS AND METHODS {#s4}
=====================

*F. verticillioides* media and growth conditions. {#s4.1}
-------------------------------------------------

F. verticillioides M-3125 ([@B52]) was used as parental strain for the analysis of the *FUM* gene cluster (*FVEG_00315* to *FVEG_00329*) ([@B11], [@B21], [@B22]). General maintenance of fungal strains was performed on solidified complete medium ([@B53]). For the cultivation of strains in liquid culture, 100 ml of Darken preculture ([@B54]) in 300-ml Erlenmeyer flasks was inoculated with a piece of mycelium and shaken for 3 days at 180 rpm and 28°C. Then, 250 μl of the preculture was transferred to 100 ml of synthetic ICI medium (Imperial Chemical Industries, Ltd., London, UK) ([@B55]) supplemented with 6 mM glutamine (Gln) and then shaken under the same conditions for 2 or 7 days for gene expression or FB~1~ analyses, respectively.

Plasmid constructions. {#s4.2}
----------------------

Vector assembly was achieved with yeast recombinational cloning ([@B56], [@B57]). Deletion vectors harbored ∼1 kb upstream and downstream flanks of the gene of interest, as well as a deletion cassette. Flanks were amplified using proofreading polymerase, primer pairs 5F/5R and 3F/3R (see Table S1 in the supplemental material), as well as F. verticillioides genomic DNA (gDNA). *FUM17*, *FUM18* and *FUM19* were deleted by exchange with the hygromycin B resistance gene under the control of A. nidulans *PgpdA*; for that purpose, *hphR* was amplified from pUC-hph ([@B58]) with hph_F/hph_R. Furthermore, deletion of *FUM21* was achieved with the nourseothricin resistance gene under the control of A. nidulans *PtrpC*, and *natR* was amplified from pZPnat1 (GenBank accession no. AY631958.1) with nat1_F/nat1_R. S. cerevisiae BY4741 (Euroscarf, Oberursel, Germany) was transformed with the obtained fragments, as well as with the XbaI/HindIII-digested shuttle vector pYES2 (Life Technologies, Darmstadt, Germany), yielding the deletion constructs ([Fig. S5](#figS5){ref-type="supplementary-material"} to [S7](#figS7){ref-type="supplementary-material"}).
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Verification of *FUM17* and *FUM18* single mutants by diagnostic PCR and Southern blot. (A) Deletion of *FUM17* via homologous recombination with the hygromycin B resistance cassette (*hphR*). Diagnostic PCR verified the correct recombination of 5′ and 3′ flanks, and the absence of WT gene for three independent transformants. Genomic DNA of transformants and WT was digested with EcoRI, and the 3′ flank was applied for probing. (B) Deletion of *FUM18* via homologous recombination with *hphR*. Genomic DNA was digested with XhoI, and the 5′ flank was applied for probing. (C) Complementation of Δ*fum18* with the full-length gene and nourseothricin resistance cassette (*natR*). Genomic DNA was digested with XhoI, and the 5′ flank was applied for probing. *FUM18^C^* T9 showed an ectopic integration and was not chosen for further analyses. Download FIG S5, PDF file, 1.8 MB.
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For *in locus* complementation of *FUM18* and *FUM19* ([Fig. S5](#figS5){ref-type="supplementary-material"}C and [S7](#figS7){ref-type="supplementary-material"}A), the full-length genes, including 5′ upstream sequences, were amplified with the primers fum18_5F/fum18_compl_R and fum19_5F/fum19_compl_R ([Table S1](#tabS1){ref-type="supplementary-material"}), respectively. For the generation of *FUM19^Kmut^*, the primer combinations fum19_5F/fum19_K631V_R, fum19_K631V_F/fum19_K1260V_R, and fum19_K1260V_F/fum19_compl_R were used. For *FUM19^Dmut^*, PCRs with the following primer pairs were performed: fum19_5F/fum19_D743K_R, fum19_D743K_F/fum19_D1397_R, and fum19_D1397K_F/fum19_compl_R. The nourseothricin resistance cassette, including *TtrpC*, was amplified from pZPnat1 with nat1_F/nat1_TtrpC_R. Furthermore, 3′ flanks of both genes were generated with fum18_compl_3F/fum18_3R and fum19_compl_3F/fum19_3R. As indicated above, complementation vectors were assembled by homologous recombination with the doubly digested plasmid backbone pYES2.
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Primers used in this study. Introduced overhangs required for yeast recombinational cloning are underlined. Download Table S1, PDF file, 0.1 MB.
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*FUM19* overexpression was achieved by fusing the first 1.2 kb of the gene to the constitutive A. nidulans promoter *PoliC*. To this end, the insert was amplified with OE_fum19_F/OE_fum19_R ([Table S1](#tabS1){ref-type="supplementary-material"}) and was cloned into NcoI/NotI-digested pNDH-OGG ([@B57]). *FUM17*::*GFP* was cloned under the control of the constitutive *F. fujikuroi* promoter *Pgln1* by using the primer pair OE_fum17_F/fum17_GFP_R and the NcoI-digested vector backbone pNAH-GGT ([@B37], [@B57]). Similarly, *FUM18*::*DsRed* fusion driven by *PoliC* was achieved with the primer pair OE_fum18_F/fum18_DsRed_R and NcoI-digested pNDN-ODT ([@B57]). *CER1*::*BFP* fusion was obtained by amplifying the gene of interest with OE_cer1_F/cer1_BFP_R, *PgpdA* from pUC-hph with PgpdA_F/PgpdA_R, *BFP* from EBFP2-N1 (a gift from Michael Davidson, Addgene plasmid 54595) with BFP_F/BFP_Tgluc_R or BFP_F/BFP_Ttub_R, and subsequent cloning of these fragments into SpeI/NotI-restricted pNDH-OGG (*hphR* and *Tgluc*) or pNDN-ODT (*natR* and *Ttub*). *DsRed*::*FUM8* under the control of *PoliC* was generated by using the primers fum8_DsRed_F/fum8_Ttub_R and pNDN-ODT linearized with NotI. Finally, *FUM3*::*GFP* under the control of *PoliC* was cloned using the primers OE_fum3_F/fum3_GFP_R and NcoI-digested pNDH-OGG. These F. verticillioides overexpression vectors can be found in [Fig. S8A](#figS8){ref-type="supplementary-material"}.

Promoter exchange of S. cerevisiae *LAG1* with the inducible *TET^ON^* promoter ([Fig. S9](#figS9){ref-type="supplementary-material"}) started out by amplifying upstream and (intragenic) downstream sequences with the primer pairs lag1_5F/lag1_5R and lag1_3F/lag1_3R ([Table S1](#tabS1){ref-type="supplementary-material"}), respectively, based on BY4741 gDNA. The histidine *HIS3* marker gene, including promoter and terminator sequences, was generated with his3_Prom_TET_F/his3_Term_R from gDNA of a prototrophic S. cerevisiae strain (Jena Microbial Research Collection, accession no. STI25222). *TET^ON^* ([@B59]) was amplified with TET_F/TET_R, and the complete vector was assembled under the use of doubly digested pYES2 as indicated above.

Finally, ceramide synthase yeast complementation vectors were constructed ([Fig. S9A](#figS9){ref-type="supplementary-material"}) by amplification of the inserts with the primer combination Tef1_F/Cyc1T_R ([Table S1](#tabS1){ref-type="supplementary-material"}) based on F. verticillioides cDNA, S. cerevisiae gDNA, or human HT29-MTX ([@B33]) cDNA. Coexpression of two genes from the same promoter was achieved by inserting the viral 2A sequence in between, yielding one large polycistronic mRNA that gives individual proteins upon cotranslational cleavage ([@B59]). To this end, double-stranded DNA was gained from the 2A_F/2A_R primer combination ([Table S1](#tabS1){ref-type="supplementary-material"}) via boiling and subsequent annealing at room temperature. The ceramide synthase genes were expressed under the control of the constitutive yeast promoter *Ptef1* by cloning the obtained fragments into the SmaI/PvuII-digested vector backbone pYES2::*Ptef1* ([@B59]). All of the above-described expression vectors were verified by sequencing using primers listed in [Table S1](#tabS1){ref-type="supplementary-material"}.

*F. verticillioides* transformation and analysis of transformants. {#s4.3}
------------------------------------------------------------------

Protoplast transformation of F. verticillioides was carried out as described elsewhere ([@B60]). Transformants were selected on plates with 200 μg/ml hygromycin B (InvivoGen Europe, Toulouse, France) and/or 200 μg/ml nourseothricin (Jena Bioscience, Jena, Germany). Linear deletion and complementation constructs were transformed. Deletion fragments and *FUM18^C^* were amplified from the assembled vectors with primers 5F/3R ([Table S1](#tabS1){ref-type="supplementary-material"}). For *FUM19* complementation and point mutation, 40 μg of each vector was linearized with SpeI prior to transformation. Homologous recombination of the flanks and absence of untransformed nuclei were tested by diagnostic PCR, while Southern blot experiments excluded additional ectopic integration events. It was made sure that complemented strains were only able to grow on nourseothricin (complementation phenotype) but were unable to grow on hygromycin B (deletion phenotype). Two to four independent transformants were verified for Δ*fum17* ([Fig. S5A](#figS5){ref-type="supplementary-material"}), Δ*fum18* ([Fig. S5B](#figS5){ref-type="supplementary-material"}), *FUM18^C^* ([Fig. S5C](#figS5){ref-type="supplementary-material"}), Δ*fum17/18* ([Fig. S6A](#figS6){ref-type="supplementary-material"}), Δ*fum17-19* ([Fig. S6B](#figS6){ref-type="supplementary-material"}), Δ*fum19*, *FUM19^C^*, *FUM19^Kmut^*, and *FUM19^Dmut^* ([Fig. S7A](#figS7){ref-type="supplementary-material"}), and Δ*fum21* and Δ*fum19*/Δ*fum21* ([Fig. S7B](#figS7){ref-type="supplementary-material"}) mutants.
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Verification of Δ*fum17/18* double and Δ*fum17-19* triple mutants by diagnostic PCR and Southern blot. (A) Deletion of *FUM17/18* via homologous recombination with the hygromycin B resistance cassette (*hphR*). Diagnostic PCR verified the correct recombination of 5′ and 3′ flanks, and the absence of WT signal for three independent transformants. Genomic DNA of transformants and WT was digested with SalI, and the 3′ flank was applied for probing. Δ*fum17/18* T7 showed an ectopic integration and was not chosen for further analyses. (B) Deletion of *FUM17-19* via homologous recombination with *hphR*. Genomic DNA was digested with SalI, and the 5′ flank was applied for probing. Δ*fum17-19* T4 showed an ectopic integration and was not chosen for further analyses. Download FIG S6, PDF file, 1.5 MB.

This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

10.1128/mBio.00455-20.7

Verification of *FUM19* and *FUM21* mutants by diagnostic PCR and Southern blot. (A) Deletion of *FUM19* via homologous recombination with the hygromycin B resistance cassette (*hphR*) and subsequent complementation with the full-length (point-mutated) gene and nourseothricin resistance cassette (*natR*). Diagnostic PCR verified the correct recombination of 5′ and 3′ flanks, and the absence of untransformed nuclei for four independent Δ*fum19*, *FUM19^C^*, *FUM19^Kmut^*, and *FUM19^Dmut^* mutants, respectively. Genomic DNA of transformants and WT was digested with BglII, and the 5′ flank was applied for probing. Δ*fum19* T29 showed an ectopic integration and was not chosen for further analyses. (B) Deletion of *FUM21* in the WT and Δ*fum19* backgrounds via homologous recombination with *natR*. Genomic DNA was digested with XbaI, and the 5′ flank was applied for probing. Download FIG S7, PDF file, 2.8 MB.
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Verification of F. verticillioides overexpression strains by diagnostic PCR. (A) Vectors for constitutive expression of the first 1.2 kb of *FUM19* (*PoliC*), as well as full-length fusion genes *FUM17*::*GFP* (*Pgln1*), *FUM18*::*DsRed* (*PoliC*), *CER1*::*BFP* (*PgpdA*), *DsRed*::*FUM8* (*PoliC*), and *FUM3*::*GFP* (*PoliC*). (B to I) Diagnostic PCR verified the *in locus* integration of circular pOE::*FUM19^1.2\ kb^*, giving full-length *FUM19*, as well as the ectopic integration of the other circular vectors, yielding indicated single and double mutants. The tested PCR signals were absent in the WT control. Download FIG S8, PDF file, 1.9 MB.
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Ceramide synthase complemented yeast strains. (A) S. cerevisiae, F. verticillioides, and human ceramide synthase genes were expressed under control of the constitutive yeast promoter *Ptef1*. pYES2::*Ptef1* was used for cloning and served as empty vector control. (B) Promoter exchange of S. cerevisiae *LAG1* using the inducible *TET^ON^* promoter and *HIS3* marker gene. (C) S. cerevisiae Δ*lac1*/TET::*LAG1* strains, harboring the respective *Ptef1* ceramide synthase plasmids (PCR *Ptef1*-*Tcyc1*), showed correct recombination of TET::*LAG1* 5′ flank, and absence of *LAC1* WT signal (see [Fig. 6A](#fig6){ref-type="fig"} and [C](#fig6){ref-type="fig"}). (D) S. cerevisiae WT, Δ*lac1*, and Δ*lag1* strains harboring *Ptef1*::*FvCER3* (see [Fig. 6B](#fig6){ref-type="fig"}). (E) S. cerevisiae WT strain harboring *Ptef1*::*FvCER1*, *Ptef1*::*FvCER2*, and *Ptef1*::*FUM18* (see [Fig. 6D](#fig6){ref-type="fig"}). Download FIG S9, PDF file, 2.1 MB.
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Furthermore, 20 to 40 μg of each circular vector was transformed to achieve overexpression of *FUM19* as well as expression of tagged *FUM17*, *FUM18*, *CER1*, *FUM8*, and *FUM3*. Homologous integration of the vector to gain full-length *FUM19* was verified for three independent OE::*FUM19* mutants ([Fig. S8B](#figS8){ref-type="supplementary-material"}). In addition, diagnostic PCR verified the ectopic integration in two to three independent single or double mutants: OE::*FUM17*::*GFP* ([Fig. S8C](#figS8){ref-type="supplementary-material"}, [E](#figS8){ref-type="supplementary-material"}, [F](#figS8){ref-type="supplementary-material"}, and [H](#figS8){ref-type="supplementary-material"}), OE::*FUM18*::*DsRed* ([Fig. S8D](#figS8){ref-type="supplementary-material"}, [E](#figS8){ref-type="supplementary-material"}, and [G](#figS8){ref-type="supplementary-material"}), OE::*CER1*::*BFP* ([Fig. S8F](#figS8){ref-type="supplementary-material"} and [G](#figS8){ref-type="supplementary-material"}) OE::*DsRed*::*FUM8* ([Fig. S8H](#figS8){ref-type="supplementary-material"}), and OE::*FUM3*::*GFP* ([Fig. S8I](#figS8){ref-type="supplementary-material"}).

Expression analysis via qRT-PCR. {#s4.4}
--------------------------------

Fungal strains were grown in ICI/6 mM Gln for 2 days, prior to harvest and lyophilization. RNA was isolated from ground mycelium under the use of TRI Reagent (Sigma-Aldrich, Steinheim, Germany). Next, 1.5 μg of RNA was DNase I treated and transcribed into cDNA with a ProtoScript II first-strand cDNA synthesis kit (New England Biolabs, Frankfurt/Main, Germany) and included oligo(dT) primers according to the standard protocol. For qRT-PCR, MyTaq HS Mix (Biocat, Heidelberg, Germany) was used in combination with 5% (vol/vol) EvaGreen Dye (Biotium, Fremont, CA) and black nontranslucent plates (Applied Biosystems standard; 4titude, Ltd., Berlin, Germany). Reactions were run in an Applied Biosystems QuantStudio 3 real-time PCR system and analyzed with QuantStudio design and analysis software (Life Technologies, Darmstadt, Germany). Expression of the genes of interest, as well as of the three constitutively expressed reference genes (*FVEG_11477* encoding ubiquitin, *FVEG_02524* encoding actin, *FVEG_09003* encoding a GDP-mannose transporter) ([@B37]), was determined in triplicate with primers listed in [Table S1](#tabS1){ref-type="supplementary-material"}. The annealing temperature was set to 60°C, and primer efficiencies were between 90 and 110%. Relative expression was calculated with the ΔΔ*C~T~* method ([@B61]).

FB~1~ analysis via HPLC-HRMS. {#s4.5}
-----------------------------

For FB~1~ analysis, the strains were grown in ICI/6 mM Gln for 7 days. The supernatant was separated from the mycelium by filtration through Miracloth (VWR, Darmstadt, Germany), and then culture fluids were fully cleared by centrifugation and mixed with 1:1 (vol/vol) methanol and 1% (vol/vol) naringenin as an internal standard (1 mg/ml in methanol; Sigma-Aldrich, Steinheim, Germany) to give 1 ml. For extraction of FB~1~ from washed and lyophilized mycelium, 0.1 g was extracted with 1.5 ml of ethyl acetate-methanol-dichlormethane (3:2:1, vol/vol) by vigorous shaking for 2 h ([@B37]). Then, 1 ml was evaporated to dryness, taken up in 1 ml of methanol with 1% (vol/vol) naringenin, and subjected to HPLC-HRMS after filtration through 0.2-μm PTFE filters (Carl Roth, Karlsruhe, Germany).

HPLC-HRMS measurements were conducted on a Thermo Fisher Q ExactivePlus hybrid quadrupole-Orbitrap mass spectrometer with an electrospray ion source operating in negative ionization mode with a full scan range of 100 to 1,000 *m/z* in combination with an Ultimate 3000 UHPLC system (Thermo Fisher Scientific, Dreieich, Germany). The system was equipped with a Kinetex C~18~ column (150 × 2.1 mm, 2.5 μm, 100 Å; Phenomenex, Aschaffenburg, Germany). The following elution gradient was used (solvent A, H~2~O plus 0.1% \[vol/vol\] HCOOH; solvent B, acetonitrile plus 0.1% \[vol/vol\] HCOOH): 5% B for 0.5 min, 5 to 97% B in 11.5 min, and 97% B for 3 min; flow rate of 0.3 ml/min; injection of 10 μl; and column oven at 40°C. Raw liquid chromatography-mass spectrometry data were analyzed using XCalibur (Thermo Fisher Scientific). FB~1~ peak areas were normalized against the internal standard to account for variability between runs. FB~1~ levels were related to the dry weight of the cultures, which were performed in biological triplicate.

Phylogenetic analysis. {#s4.6}
----------------------

Homologs of ceramide synthase genes were retrieved by BLASTp and/or BLASTx analyses ([@B62]) of fungal genome sequence databases at NCBI and the Joint Genome Institute. Initially, the S. cerevisiae *LAG1* and *LAC1* genes and F. verticillioides *FUM17*, *FUM18*, *CER1*, *CER2*, and *CER3* genes were used as query sequences. Subsequently, sequences from other fungal species were used to ensure that we obtained ceramide synthase sequences from diverse fungi. In some cases, gene sequences were manually annotated to correct obvious errors in automated predictions of translation start and stop sites and intron splice sites. Using BLAST, we retrieved the predicted amino acid sequences for 141 genes. We also retrieved a single homolog from both rat and human to use as an outgroup. The amino acid sequences were aligned with the MUSCLE algorithm as implemented in the program MEGA7 ([@B63]). The resulting alignment was then subjected to tree building analysis using the maximum-likelihood method as implemented in the program IQ-Tree (version 1.6.9) with ultrafast bootstrapping ([@B64]). The resulting tree was viewed and formatted with MEGA7.

Confocal microscopy. {#s4.7}
--------------------

Fungal hyphae were grown from 10^4^ conidia in 300 μl of ICI/6 mM Gln as adherent cultures in ibidi dishes (ibidi, Gräfelfing, Germany) at 30°C for 16 h. For nuclear staining, NucBlue Live ReadyProbes reagent (Thermo Fisher Scientific, Schwerte, Germany) was used according to the manufacturer's instructions. All microscopy experiments were performed on an Axio Observer Spinning Disc confocal microscope (Zeiss, Jena, Germany) with the 63× or 100× oil objectives and analyzed with ZEN 2.6 software. Fluorescent stains and proteins were excited using the 405-, 488-, and 561-nm laser lines. Postprocessing of the images for brightness adjustments was done in ImageJ (<https://imagej.nih.gov>).

Yeast complementation assay. {#s4.8}
----------------------------

The generated Δ*lac1*/TET::*LAG1* conditional null mutant was transformed with the ceramide synthase-containing complementation plasmids ([Fig. S9A](#figS9){ref-type="supplementary-material"}), and positive colonies were selected on synthetic defined medium lacking uracil (SD-Ura) plus 8 μg/ml doxycycline hyclate (AppliChem, Darmstadt, Germany). The empty vector pYES2::*Ptef1* served as the control, as well as the progenitor S. cerevisiae BY4741 and Δ*lac1* strains (Euroscarf, Oberursel, Germany). At least two independent transformants were tested per strain, and verification of all strains by diagnostic PCR is summarized in [Fig. S9C](#figS9){ref-type="supplementary-material"}. For the drop assay, an overnight culture was prepared in 5 ml of SD--Ura plus 8 μg/ml doxycycline, which was shaken at 180 rpm and 30°C. Then, 10 μl of a 1:10 dilution series in water was spotted onto SD--Ura plates with or without doxycycline, starting with an optical density at 600 nm (OD~600~) of 0.1. Growth was evaluated after 2 days at 30°C.

Resazurin cell viability assay. {#s4.9}
-------------------------------

FB~1~ growth inhibition of ceramide synthase-complemented yeast strains and F. verticillioides spores was evaluated via monitoring the reduction of resazurin to fluorescent resorufin every 30 min for up to 24 h. The experiments were conducted in a CLARIOstar plate reader (BMG Labtech, Ortenberg, Germany) with sterile black 96-well plates (BRANDplates; VWR, Darmstadt, Germany). Incubation was performed with SD--Ura at 30°C for yeast cells, while *Fusarium* spores were grown in the presence of ICI/6 mM Gln at 28°C. Each well contained 150 μl: 10 μl cells in medium (yeast, OD~600~ = 0.01; *Fusarium*, 5 × 10^4^ spores/ml final concentration), 10 μl of FB~1~ in water (250 to 500 μg/ml final concentration; Biomol, Hamburg, Germany; lot 0542168) or 10 μl of water as control, and 1.5 μl of 0.002% (wt/vol) resazurin sodium salt in water (AppliChem, Darmstadt, Germany), adjusted to the final volume with medium. Resorufin was measured at the following wavelengths: excitation at 570 nm and emission at 615 nm (as previously performed) ([@B30]). Controls without cells did not show an increase in fluorescence. Measurements were done in biological triplicate, and fluorescence measurements of each sample were normalized against its lowest starting value. Growth inhibition was calculated by comparing fluorescence maxima between treated and nontreated samples ([Fig. S4](#figS4){ref-type="supplementary-material"}).
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